Jerome Bressi
Fortuna: 905 048 $ al 30/06/2026
Fortuna: 905 048 $ al 30/06/2026
Jerome C.
Bressi formerly worked at Hyperion Therapeutics, Inc., as President-BioPharma Regulatory Solutions and Fate Therapeutics, Inc., as Senior VP-Regulatory Affairs & Quality Assurance from 2018 to 2025.
Dr. Bressi received his doctorate degree from the University of Washington and undergraduate degree from the University of California.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
FATE THERAPEUTICS, INC. 0,29 % | 15/01/2025 | 335.203 ( 0,29 % ) | 905 048 $ | 30/06/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| FATE THERAPEUTICS, INC. | Consejero General | 01/02/2025 |
| HYPERION THERAPEUTICS INC | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Hyperion Therapeutics, Inc.
Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.